BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12182875)

  • 21. Role of aromaticity of agonist switches of angiotensin II in the activation of the AT1 receptor.
    Miura S; Feng YH; Husain A; Karnik SS
    J Biol Chem; 1999 Mar; 274(11):7103-10. PubMed ID: 10066768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An investigation of angiotensin II agonist and antagonist analogues with 5,5-dimethylthiazolidine-4-carboxylic acid and other constrained amino acids.
    Samanen J; Cash T; Narindray D; Brandeis E; Adams W; Weideman H; Yellin T; Regoli D
    J Med Chem; 1991 Oct; 34(10):3036-43. PubMed ID: 1920354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation in positions 1 and 7 of angiotensin II. A structure-activity relationship study.
    Cordopatis P; Manessi-Zoupa E; Theodoropoulos D; Bossé R; Bouley R; Gagnon S; Escher E
    Int J Pept Protein Res; 1994 Oct; 44(4):320-4. PubMed ID: 7875933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of methylation of the histidine ring of [Sar1]angiotensin II on conformation and biological activity.
    Moore GJ; Goghari MH; Franklin KJ
    Int J Pept Protein Res; 1993 Nov; 42(5):445-9. PubMed ID: 8106195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N- and C-terminal structure-activity study of angiotensin II on the angiotensin AT2 receptor.
    Bouley R; Pérodin J; Plante H; Rihakova L; Bernier SG; Maletínská L; Guillemette G; Escher E
    Eur J Pharmacol; 1998 Feb; 343(2-3):323-31. PubMed ID: 9570482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological activities of angiotensin II, Sarilesin, and Sarmesin analogues containing Aze or Pip at position 7.
    Matsoukas JM; Agelis G; Hondrelis J; Yamdagni R; Wu Q; Ganter R; Smith JR; Moore D; Moore GJ
    J Med Chem; 1993 Apr; 36(7):904-11. PubMed ID: 8464045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives.
    Agelis G; Resvani A; Durdagi S; Spyridaki K; Tůmová T; Slaninová J; Giannopoulos P; Vlahakos D; Liapakis G; Mavromoustakos T; Matsoukas J
    Eur J Med Chem; 2012 Sep; 55():358-74. PubMed ID: 22889560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, conformational analysis, and biological studies of urotensin-II lactam analogues.
    Grieco P; Carotenuto A; Patacchini R; Maggi CA; Novellino E; Rovero P
    Bioorg Med Chem; 2002 Dec; 10(12):3731-9. PubMed ID: 12413830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindoles.
    Dhanoa DS; Bagley SW; Chang RS; Lotti VJ; Chen TB; Kivlighn SD; Zingaro GJ; Siegl PK; Patchett AA; Greenlee WJ
    J Med Chem; 1993 Dec; 36(26):4230-8. PubMed ID: 8277505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological and conformational evaluation of angiotensin II lactam bridge containing analogues.
    Oliveira VX; Fázio MA; Silva AF; Campana PT; Pesquero JB; Santos EL; Costa-Neto CM; Miranda A
    Regul Pept; 2011 Dec; 172(1-3):1-7. PubMed ID: 21787808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards non-peptide ANG II AT1 receptor antagonists based on urocanic acid: rational design, synthesis and biological evaluation.
    Agelis G; Resvani A; Matsoukas MT; Tselios T; Kelaidonis K; Kalavrizioti D; Vlahakos D; Matsoukas J
    Amino Acids; 2011 Feb; 40(2):411-20. PubMed ID: 20607324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II receptor antagonists.
    van Meel JC; Entzeroth M; Hauel N; Narr B; Ries U; Wienen W
    Arzneimittelforschung; 1993 Feb; 43(2A):242-6. PubMed ID: 8498971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of motilin antagonists derived from the [1-4] fragment of porcine motilin.
    Haramura M; Okamachi A; Tsuzuki K; Yogo K; Ikuta M; Kozono T; Takanashi H; Murayama E
    J Med Chem; 2002 Jan; 45(3):670-5. PubMed ID: 11806718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An effort to understand the molecular basis of hypertension through the study of conformational analysis of losartan and sarmesin using a combination of nuclear magnetic resonance spectroscopy and theoretical calculations.
    Mavromoustakos T; Kolocouris A; Zervou M; Roumelioti P; Matsoukas J; Weisemann R
    J Med Chem; 1999 May; 42(10):1714-22. PubMed ID: 10346924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformation and bioactivity. Design and discovery of novel antihypertensive drugs.
    Mavromoustakos T; Zervou M; Zoumpoulakis P; Kyrikou I; Benetis NP; Polevaya L; Roumelioti P; Giatas N; Zoga A; Minakakis PM; Kolocouris A; Vlahakos D; Grdadolnik SG; Matsoukas J
    Curr Top Med Chem; 2004; 4(4):385-401. PubMed ID: 14965308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorescence properties of angiotensin II analogues in receptor-simulating environments: relationship between tyrosinate fluorescence lifetime and biological activity.
    Turner RJ; Matsoukas JM; Moore GJ
    Biochim Biophys Acta; 1991 May; 1065(1):21-8. PubMed ID: 2043649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin analogues palmitoylated in positions 1 and 4.
    Maletínská L; Neugebauer W; Pérodin J; Lefebvre M; Escher E
    J Med Chem; 1997 Sep; 40(20):3271-9. PubMed ID: 9379447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imidazole-5-acrylic acids: potent nonpeptide angiotensin II receptor antagonists designed using a novel peptide pharmacophore model.
    Keenan RM; Weinstock J; Finkelstein JA; Franz RG; Gaitanopoulos DE; Girard GR; Hill DT; Morgan TM; Samanen JM; Hempel J
    J Med Chem; 1992 Oct; 35(21):3858-72. PubMed ID: 1433195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetrazole analogues of cyclolinopeptide A: synthesis, conformation, and biology.
    Kaczmarek K; Jankowski S; Siemion IZ; Wieczorek Z; Benedetti E; Di Lello P; Isernia C; Saviano M; Zabrocki J
    Biopolymers; 2002 May; 63(6):343-57. PubMed ID: 11920436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological reactivity of angiotensin II receptor antagonists: possible implications for receptor binding sites.
    Bensoussan M; Mitchell T; Reilly T; Timmermans PB; Verroust PJ; Ronco PM
    Eur J Pharmacol; 1993 Oct; 247(2):169-75. PubMed ID: 8282006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.